Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05012878 · ClinicalTrials.gov registry record · NA
Cardiac Rehab and Cerebral Blood Flow Study
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 45
- Enrollment target
NCT05012878: Completed NA study, sponsored by Mayo Clinic.
NCT05012878 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 45 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05012878, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
Study Summary
This study is being done to better understand the influence of cardiovascular disease on brain blood flow regulation and cognitive function, determine whether exercise-based cardiac rehabilitation can lead to better regulation of brain blood flow that may help to improve or maintain cognitive function, and determine whether exercise intensity influences changes in brain blood flow regulation and cognitive function.
Primary Outcome
Measured as the change in cerebral blood flow during a stepped protocol of increases in inhaled carbon dioxide concentrations. Reactivity will be measured as the regression slope of cerebral blood flow velocity (cm per second) per mmHg increase in end-tidal carbon dioxide.
Interventions
- BEHAVIORAL Cardiac rehabilitation - high intensity interval training (HIIT)
- BEHAVIORAL Cardiac rehabilitation - moderate intensity continuous training (MICT)
- BEHAVIORAL Cardiac rehabilitation - control
- BEHAVIORAL Cardiac rehabilitation - observational
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2021-09-02 |
| Est. Completion | 2025-04-23 |
| Phase | NA |
What the finished NCT05012878 record still lists
NCT05012878 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 4 interventions - of which Cardiac rehabilitation - high intensity interval training (HIIT) is the first listed.
NCT05012878 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05012878 about?
NCT05012878 is a clinical study titled "Cardiac Rehab and Cerebral Blood Flow Study". This study is being done to better understand the influence of cardiovascular disease on brain blood flow regulation and cognitive function, determine whether exercise-based cardiac rehabilitation can lead to better regulation of brain blood flow that may help to improve or maintain cognitive functi...
What is the current status of trial NCT05012878?
This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 2021-09-02. Estimated completion is 2025-04-23.
What interventions are being tested in trial NCT05012878?
The interventions under investigation include: Cardiac rehabilitation - high intensity interval training (HIIT) (BEHAVIORAL), Cardiac rehabilitation - moderate intensity continuous training (MICT) (BEHAVIORAL), Cardiac rehabilitation - control (BEHAVIORAL), Cardiac rehabilitation - observational (BEHAVIORAL).
Who is sponsoring clinical trial NCT05012878?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05012878's enrollment target sits among peer trials
45 1411th of 2000 higher than 578 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI